A 25-year-old male with an existing diagnosis activated his CancerCARE benefit. The patient reported a diagnosis of a rare, high-risk subtype of Hodgkin’s disease. The patient was receiving treatment for this initial diagnosis. Upon activating his CancerCARE® benefit, the patient’s samples were sent to a Center of Excellence for diagnosis confirmation. The second opinion determined that the patient had classical Hodgkin’s disease, not the high-risk diagnosis he originally received. With CancerCARE’s help, the patient’s treatment was adjusted and his overall outcome was improved.